The acquisition is financially immaterial and involves an insider seller, limiting its significance. Monitor for future quarterly results to see if Meduvo contributes meaningfully to revenue or if ETST pursues larger, arms-length acquisitions. The sterile-compounding upgrade target (end of 2028) is too distant for immediate trading catalysts.
Price Chart
Executive Summary
Earth Science Tech, Inc. (ETST) acquired Meduvo LLC, a California compounding pharmacy, in an immaterial related-party transaction from COO Mario G. Tabraue. The deal adds 34-state dispensing authority and a West Coast hub, but the immaterial value and insider seller limit the strategic weight.
Key Facts
- Acquisition of Meduvo LLC, a compounding pharmacy in La Verne, CA, announced August 11, 2026
- Seller was COO and board member Mario G. Tabraue — related-party transaction reviewed by independent directors
- Terms not disclosed because the amount is 'immaterial' (per the filing)
- Meduvo currently operates a 2,000 sq ft facility compounding non-sterile medications; ETST plans upgrades for sterile certification by end of 2028
- Acquisition expands ETST's dispensing network to 34 U.S. jurisdictions
Financial Impact
Not disclosed — stated as immaterial; no purchase price or financial metrics provided
Risk Factors
- Immateral deal size means negligible near-term financial impact
- Related-party transaction introduces governance overhang despite independent review
- Sterile compounding certification is two years out with no guaranteed timeline or cost estimates
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-037339 |
| Exhibit: ex99-1.htm | 0001493152-26-037339 |
| Document: 0001493152-26-037339-index-headers.html | 0001493152-26-037339 |
| Document: 0001493152-26-037339-index.html | 0001493152-26-037339 |
| Document: 0001493152-26-037339.txt | 0001493152-26-037339 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 8-K | $0.0899 | awaiting T+20 | — | $0.0947 (+5.34%) |
Sep 1, 2026 8w ago | 8-K | $0.0880 $0.0911 | ▲ +3.52% | ▲ +2.34% | $0.0947 (+7.61%) |
Aug 19, 2026 9w ago | 8-K | $0.1070 $0.0900 | ▼ −15.89% | ▼ −14.37% | $0.0947 (−11.50%) |
Aug 12, 2026 10w ago | 8-K | $0.0921 $0.0900 | ▼ −2.28% | ▼ −0.53% | $0.0947 (+2.82%) |
Aug 7, 2026 11w ago | 8-K | $0.0979 $0.0900 | ▼ −8.07% | ▼ −7.67% | $0.0947 (−3.27%) |
Jun 18, 2026 18w ago | 8-K | $0.1760 $0.1400 | ▼ −20.45% | ▼ −19.99% | $0.0947 (−46.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers